Fanelli F, Menziani M C, De Benedetti P G
Dipartimento di Chimica, Università di Modena, Italy.
Protein Eng. 1995 Jun;8(6):557-64. doi: 10.1093/protein/8.6.557.
Molecular dynamics simulations of the hamster alpha 1B-adrenergic and the rat m3-muscarinic seven-helix bundle receptor models have been carried out. The free, agonist-bound and antagonist-bound forms have been considered. Moreover, three mutant forms of the m3-muscarinic receptor (N507-->A, N507-->D and N507-->S) have also been simulated; among these, the N507-->S mutant shows a constitutive activity. A comparative structural/dynamics analysis has been performed to elucidate (i) the perturbations induced by the functionally different ligands upon binding to their target receptor, (ii) the features of the three single-point mutants with respect to the receptor wild type and (iii) the properties shared by the agonist-bound forms of the alpha 1B-adrenergic receptor and the m3-muscarinic receptor and by the constitutively active mutant N507-->S. The consistency obtained between the structural rearrangement of the transmembrane seven-helix bundle models considered, and the experimental pharmacological efficacies of the ligands and of the mutants, constitute an important validation of the 3-D models obtained and allow the inference of the mechanism of ligand- or mutation-induced receptor activation at the molecular level.
已经对仓鼠α1B - 肾上腺素能受体和大鼠M3 - 毒蕈碱型七螺旋束受体模型进行了分子动力学模拟。考虑了游离形式、激动剂结合形式和拮抗剂结合形式。此外,还模拟了M3 - 毒蕈碱型受体的三种突变形式(N507→A、N507→D和N507→S);其中,N507→S突变体表现出组成型活性。进行了比较结构/动力学分析,以阐明:(i)功能不同的配体与它们的靶受体结合时引起的扰动;(ii)相对于受体野生型,三个单点突变体的特征;以及(iii)α1B - 肾上腺素能受体和M3 - 毒蕈碱型受体的激动剂结合形式与组成型活性突变体N507→S共有的特性。所考虑的跨膜七螺旋束模型的结构重排与配体和突变体的实验药理效力之间获得的一致性,构成了对所获得的三维模型的重要验证,并允许在分子水平上推断配体或突变诱导的受体激活机制。